Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients

By Howles C. M.   Saunders H.   Alam V.   Engrand P.    

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 907-918

Informa Healthcare

Access to resources Recommend Favorite

Seminal anti‐Müllerian hormone levels during recombinant human follicle‐stimulating hormone treatment in men with idiopathic infertility undergoing assisted reproduction cycles

By  

ANDROLOGY, Vol. 3, Iss. 5, 2015-09 ,pp. : 843-847

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mole modifications following controlled ovarian stimulation for assisted reproduction technologies

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 926-9959, Iss. 10, 2015-10 ,pp. : 1913-1917

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mole modifications following controlled ovarian stimulation for assisted reproduction technologies

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 10, 2015-10 ,pp. : 1913-1917

John Wiley & Sons Inc

Access to resources Recommend Favorite

Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effect

By O'Dea Louis   O'Brien Fanny   Currie Karen   Hemsey George  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2785-2793

Informa Healthcare

Access to resources Recommend Favorite